Clinical Kidney Journal

Article	Citations
Prolonged normothermic perfusion: a promising approach to kidney transplantation	170
A puzzling renal Fanconi syndrome	96
Donor-derived membranous nephropathy	86
Correction to: Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials	74
Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathy	65
Leicestershire and rutland chronic kidney disease integrated care delivery (LUCID) programme update: the impact on novel kidney therapies	56
Novel eGFR equations and cardiovascular outcomes in a multiethnic Asian cohort	56
ECOSBot: a multicenter validation pilot study of a generative AI tool for OSCE-based nephrology training	53
Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis	52
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysis	49
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres	47
Interaction of general obesity and abdominal obesity with frailty in patients with chronic kidney disease: a nationally representative analysis	46
Toward acid- and heparin-free dialysis: the regional anticoagulation approach	44
Differentiating primary and secondary FSGS using non-invasive urine biomarkers	43
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients	41
Correction to: Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis	40
Bilateral nephrectomy in autosomal dominant polycystic kidney disease patients before or after renal transplantation: data from a retrospective cohort study	40
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort	40
Can exercise improve outcomes for frail haemodialysis patients?	39
Recent advances in pathogenetic concepts and disease modeling of IgA nephropathy	38
Ten tips on how to manage kidney health in migrants and refugees	38
Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging	36
Galectin-3 as a prognostic biomarker in haemodialysis patients with preserved or mildly reduced ejection fraction	36
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis	36
Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR	36

Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study	35
Cerebral blood flow following successful living kidney transplantation: the VINTAGE study	35
Informal caregiver burden in dialysis care and how it relates to patients’ health-related quality of life and symptoms	35
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA2023	34
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study	34
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	34
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective	34
Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease	32
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function	31
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease	31
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations	31
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal	31
More dissimilarities than affinities between DNAJB11-PKD and ADPKD	31
Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study	30
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study	30
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus	30
Complications on the feeding artery after an arterio-venous fistula closure in patients after kidney transplantation – a national cohort study	29
Biomarkers in clinical epidemiology studies	29
The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trial	29
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic	29
Lower serum magnesium levels are associated with a higher risk of fractures and vascular calcifications in hemodialysis patients	29
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study	29
Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?	28
Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney disease	28
Cerebral white matter injury in haemodialysis patients: a cross-sectional tract-based spatial statistics and fixel-based analysis	28
Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients	28
International validation of a pre-transplant risk assessment tool for graft survival in pediatric kidney transplant recipients	28
Fibrillary glomerulonephritis: an observational study of clinical-pathological features and outcomes in patients from a multi-institutional cohort	27
Self-limited, sodium-dependent osmotic diuresis causes polyuria after living donor kidney transplantation	27
The burden of hyperkalaemia in chronic kidney disease: a systematic literature review	27
Association between beta-blocker utilization and heart failure mortality in the peritoneal dialysis population: a cohort study	27
Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19	27
Glycemic control and complications in hemodialysis patients: the TURK-HEMODIAB STUDY	27
Efficacy and safety of belimumab in refractory and newly diagnosed active lupus nephritis patients: a real-world observational study	27
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry	26
Glomerular endothelial injury following vaccination for SARS-CoV-2	26
The role of low health literacy in shared treatment decision-making in patients with kidney failure	26
Introduction to new CKJ section: In Context – in collaboration with YNP	26
Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease	25
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials	24
Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis	24
Ultrafiltration rate and mortality in patients undergoing extended-hours haemodialysis	24
Strategies to prevent SARS-CoV-2 transmission in hemodialysis centres across Europe—lessons for the future	24
Wasp stings and plasma exchange	24
Cardiometabolic protein expression levels and pathways associated with kidney function decline in older European adults with advanced kidney disease	24
Acute kidney injury due to inhalation of metal fumes	24
Addressing cognitive impairment in peritoneal dialysis: a systematic review and meta-analysis of prevalence, risk factors, and outcomes	23
Genetic and clinical characterization of familial renal glucosuria	23
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients	23
Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study	23

Coordinating efforts to optimize next-generation kidney replacement therapies: the European Kidney Health Alliance Work Group ‘Breakthrough Innovation’	23
The integrated care model: facilitating initiation of or transition to home dialysis	23
Multiomic profiling of new-onset kidney function decline: insights from the STANISLAS study cohort with a 20-year follow-up	23
Visit-to-visit variability in blood pressure and kidney disease progression in IgA nephropathy	22
Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease	22
Treatment of primary hyperoxaluria type 1	22
Understanding and targeting senescence in kidney disease	22
Renal function is highly associated with podiatric risk in diabetic patients	22
Epidemiological risk factors for acute kidney injury outcomes in hospitalized adult patients: a multicenter cohort study	22
The Many Faces of NELL1 MN	22
Treatment of acute kidney injury in cancer patients	22
The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease	21
How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies	21
Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications	21
Kidney Donor Profile Index and allograft outcomes: interactive effects of estimated post-transplant survival score and ischaemic time	21
Should we enlarge the indication for kidney biopsy in patients with diabetes? The pro part	21
Induction therapy for class I/II lupus nephritis with glucocorticoid monotherapy associates with higher relapse and poorer kidney outcomes	20
Precision medicine for the treatment of glomerulonephritis: a bold goal but not yet a transformative achievement	20
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseases	20
Estimating 24-hour urine phosphate excretion from spot urine	20
Remote management of anaemia in patients with end-stage kidney disease using a wearable, non-invasive sensor	20
Novel NUP160 mutations related to simultaneous congenital nephropathy and ovarian insufficiency	20
Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetes	20
RNA therapeutics in kidney diseases: prospects and current status	20
Prevalence, awareness, treatment, and control of hypertension in community-dwelling older adults with chronic kidney disease: the Irish longitudinal study on ageing	20
A 20-year follow-up study of identical twin sisters with immunoglobulin A nephropathy	20
Association of deprivation and its individual domains on outcomes in people with chronic kidney disease	20
Renal outcomes in immunoglobulin A nephropathy following COVID-19 vaccination: a retrospective cohort study	19
Predicting prognosis in ANCA-associated vasculitis with kidney involvement	19
Valvular heart disease in patients on kidney replacement therapy: “opening Pandora's box”	19
Correction to: Decongestion in patients with advanced chronic kidney disease coexisting with heart failure	19
Implementing a model of integrated CKD management between primary and secondary care	19
Potassium management and heart failure: a nephrologist's perspective	19
Designing qualitative research with value in the clinical and epidemiological context: what, why and how	19
Personalizing electrolytes in the dialysis prescription: what, why and how?	19
Probiotics for kidney disease	19
Partnering with patients and caregivers to enrich research and care in kidney disease: values and strategies	18
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis	18
Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy	18
Fatigue across different chronic kidney disease populations: experiences and needs of patients	18
Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies	18
Urgent initiation of hemodialysis versus peritoneal dialysis in severe hyperkalemia: a prospective study	18
What to do with key cardiovascular drugs when kidney function worsens?	18
Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease	18
From electronic health records to clinical management systems: how the digital transformation can support healthcare services	18
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	18
Genetic testing in focal segmental glomerulosclerosis: in whom and when?	18
Chronic prescription of antidepressant medication in patients with chronic kidney disease with and without kidney replacement therapy compared with matched controls in the Dutch general population	18
Long-term effect of increasing water intake on repeated self-assessed health-related quality of life (HRQoL) in autosomal dominant polycystic kidney disease	17
Anti-phospholipid antibodies nephropathy is associated with an increased risk of kidney failure: a systematic literature review and meta-analysis	17
Integrating multiple kidney function markers to predict all-cause and cardiovascular disease mortality: prospective analysis of 366 758 UK Biobank participants	17
Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation	17
Novel equations for estimating intraperitoneal pressure among peritoneal dialysis patients	17
Dynamic prediction of kidney allograft and patient survival using post-transplant estimated glomerular filtration rate trajectory	17
Mucosal-associated invariant T-cells and the gut-kidney axis: a review	17
Automating kidney transplant rejection diagnosis: a simple solution for a complex problem?	17
Telitacicept versus mycophenolate mofetil in IgA nephropathy: a real-world comparative study of efficacy, renal outcomes and safety	17
Correction to: Clinical implications of mineralocorticoid receptor overactivation	17
Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial	17
Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-up	17
Differences in association between hypoalbuminaemia and mortality among younger versus older patients on haemodialysis	16
New aspects in cardiorenal syndrome and HFpEF	16
The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment	16
Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response	16
Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction	16
Anticoagulation in patients with end-stage kidney disease and atrial fibrillation: a national population-based study	16
Management of hypertension in patients with cancer: challenges and considerations	16
Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003–21	16
Integrative analysis of the association between circadian rhythm and lupus nephritis	16
Three decades of CKD due to diabetes mellitus type 2 in China, with projections of disease burden from 2022 to 2036: a systematic analysis for the Global Burden of Disease Study 2021	16
Machine learning models for mortality prediction in critically ill patients with acute pancreatitis–associated acute kidney injury	16
Renal involvement is frequent in adults with primary mitochondrial disorders: an observational study	16
Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors	16
Liver safety of tolvaptan in patients with autosomal dominant polycystic kidney disease: interim data from a post-authorization safety study	16
The role of blood purification therapies in the treatment of chronic kidney disease–associated pruritus: a systematic review	16
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease	15
Rituximab as a first-line therapy in children with new-onset idiopathic nephrotic syndrome	15
Multiparametric MRI: can we assess renal function differently?	15
Ageing meets kidney disease	15
National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study	15

New and old GFR equations: a European perspective	15
Collagen type III formation but not degradation is associated with risk of kidney disease progression and mortality after acute kidney injury	15
Decoy receptors as biomarkers for exploring aetiology and designing new therapies	15
Urinary soluble PD-1 as a biomarker of checkpoint inhibitor-induced acute tubulointerstitial nephritis	15
Reply to ‘Depression and clinical outcomes in CKD: do anti-depressants play a role? (EQUAL Study)’	14
Current practices in prevention, screening, and treatment of diabetes in kidney transplant recipients: European survey highlights from the ERA DESCARTES Working Group	14
COVID-19 among kidney transplant recipients: evaluating risk factors during the initial phase of the pandemic	14
Association of albuminuria with incident atrial fibrillation in healthy older adults	14
Correction to: Moving on obesity treatment in CKD: inertia is unjustified	14
2025 Update on resistant hypertension in CKD: where do we stand and where do we go?	14
A review of supportive care for older people with advanced chronic kidney disease	14
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices	14
Prospective study of the effect of rituximab on kidney function in membranous nephropathy	14
Mortality associated with the COVID-19 pandemic in the Swiss dialysis population beyond SARS-CoV-2 infection	14
Personalized peritoneal dialysis prescription—beyond clinical or analytical values	14
Nafamostat mesylate has advantages as an anticoagulant for patients undergoing maintenance hemodialysis with conjunctival bleeding	14
Association between serum short-chain fatty acid levels and the risk of all-cause and cardiovascular disease mortality in Chinese patients undergoing maintenance hemodialysis: a retrospective cohort s	14
Trunk muscle quality and quantity are associated with renal volume in nondiabetic people	14
Epigenetic mechanisms of salt-sensitive hypertension	14
Hyponatremia and the risk of sepsis in the setting of chronic kidney disease not on dialysis	14
Prophylactic proton pump inhibitor usage and new-onset acute kidney injury in critically ill patients: a retrospective analysis	14
Asymmetric dimethylarginine and citrulline are risk factors for cardiovascular disease independently of both estimated and measured GFR	14
Immobilization-associated hypercalcaemia in patients with malignancy in the hospital setting	14
Defining diagnostic trajectories in patients with podocytopathies	14
Anti-nephrin antibody: a potential biomarker of minimal change disease	14
Incidence and prognosis of acute kidney injury versus acute kidney disease among 71 041 inpatients	14
Synergistic effect of teclistamab with PD-1 inhibition: a case of acute interstitial nephritis with dual immunotherapy	13
Considering the utility of urinary amino acids for early identification of non-diabetic chronic kidney disease	13
Malignancies and glomerulonephritis: when to suspect and when to screen?	13
Time-averaged concentration estimation of uraemic toxins with different removal kinetics: a novel approach based on intradialytic spent dialysate measurements	13
Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease	13
The elevation of the anion gap in steady state chronic kidney disease may be less prominent than generally accepted	13
Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease	13
New trials in resistant hypertension: mixed blessing stories	13
The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients	13
Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort	13
Performance of an interstitial glucose monitoring device in patients with type 1 diabetes during haemodialysis	13
Longitudinal serum bicarbonate and mortality risk in older patients with advanced chronic kidney disease: analyses from the EQUAL cohort	13
Social deprivation as a key driver of spatial disparities in end-stage kidney disease incidence	13
Urinary microvesicles: a window into the kidney	13
Risk factors for major bleeding in patients with atrial fibrillation and CKD G3–G5D on oral anticoagulants	13
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab	13
Cardiovascular risk prediction in hemodialysis patients using the triglyceride-glucose index: a multicenter prospective cohort study	13
Reply to ‘Stability and compatibility of antibiotics in PD solutions—call for including antibiotics for drug-resistant infections’	12
Twenty-four-hour proteinuria levels are associated with adverse pregnancy outcomes among women with CKD	12
Mechanisms and treatment of obesity-related hypertension—Part 2: Treatments	12
Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?	12
Hypoxia-inducible factor prolyl hydroxylase inhibitors in kidney transplant recipients	12
Correction to: Spatially resolved transcriptomic profiling for glomerular and tubulointerstitial gene expression in C3 glomerulopathy	12
Kidney–placenta crosstalk in health and disease	12
Sodium/Glucose Cotransporter Inhibitors, Refractory Hypomagnesemia, and Recurrent Genital Mycotic Infections	12
The ERA Registry Annual Report 2019: summary and age comparisons	12
Lung ultrasonography performed by nephrologist: COVID-19 as an opportunity to reveal ultrasound's full potential and usefulness in the dialysis room	12
Kidney replacement therapy patients with COVID-19 in the vaccine era: what do we need to know?	12
Cystatin C–based estimated glomerular filtration rate and risk of stroke in the general population: a prospective cohort study	12
Cystatin C–based estimated GFR performs best in identifying individuals with poorer survival in an unselected Chinese population: results from the China Health and Retirement Longitudinal Study (CHARL	12
Incremental versus conventional haemodialysis in end-stage kidney disease: a systematic review and meta-analysis	12
Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor–associated membranous nephropathy	12
Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients	12
Healthy aging and aging-related kidney diseases: lessons from centenarians	12
ERA Registry Figure of the month Expected remaining years of life for dialysis and kidney transplant patients	11
The effect of standard percutaneous nephrolithotomy, miniaturized percutaneous nephrolithotomy and retrograde intrarenal surgery on biomarkers of renal injury: a randomized clinical trial	11
C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—an open-label pilot study	11
Ten tips to teach learners to love nephrology (and recruit the next generation)	11
Association of urinary albumin:creatinine ratio with incident frailty in older populations	11
A treasure from a barren island: the discovery of rapamycin	11
Correction to: Using artificial intelligence to predict mortality in AKI patients: a systematic review/meta-analysis	11
Disturbance in the potential cardiovascular–bone–skeletal muscle axis and morbidity and mortality in patients undergoing haemodialysis: the Q-Cohort Study	11
Uraemic burden index: a novel predictor of pre-emptive kidney transplant outcome	11
Estimation of glomerular filtration rate in cardiorenal patients: a step forward	11
Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms	11
Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change disease	11
Association of secondary prevention medication use after myocardial infarction with mortality in hemodialysis patients	11
History of creatinine clearance: tribute to a forerunner	11
Bone mineral density after exercise training in patients with chronic kidney disease stages 3 to 5: a sub-study of RENEXC—a randomized controlled trial	11
Trajectories of urea‑to‑creatinine ratio and risk of clinical outcomes in survivors of acute kidney disease: a population-based study	11
Efficacy and safety of finerenone in IgA nephropathy: an observational multicentre study	11
Chronic kidney disease duration and suicide risk among maintenance hemodialysis patients in China	11
The long-term benefits of early intensive therapy in chronic diseases—the legacy effect	11
Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis	11
Kidney Failure Risk Equation performance according to the etiology of chronic kidney disease in the CKD-CAREMEAU cohort	11
The risk of CKD progression remains high in patients treated with ACE inhibitors and ARBs, MRAs and SGLT2 inhibitors. Have we already achieved the therapeutic ceiling in CKD? (The CON part)	11
Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes	11
Real-world analysis of the impact of finerenone on estimated glomerular filtration rate and albuminuria in patients with diabetic kidney disease	11
Matrix Gla protein polymorphism rs1800802 is associated with atheroma plaque progression and with cardiovascular events in a chronic kidney disease cohort	11
Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease	11
An update on absolute and relative indications for dialysis treatment modalities	11
Long-term evaluation of the timing of corticosteroid therapy in an IgA nephropathy cohort	10
Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients	10
Measures of wave intensity as a non-invasive surrogate for cardiac function predicts mortality in haemodialysis patients	10
Association of dietary carbohydrate intake with risk of mortality in maintenance hemodialysis patients: a multicenter prospective cohort study	10
Central volume shift in acute heart failure revealed by blood volume monitoring during haemodialysis	10
Acute kidney injury after non-cardiac major surgery: has it reduced?	10
31P-MRS, molecular level imaging for assessing muscular mitochondrial dysfunction in chronic kidney disease	10
Compound heterozygous variants of ANKFY1 in a child with infantile-onset proteinuria and movement disorder	10